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Abstract  
Objectives 
We aimed to identify factors influencing the sensitivity of perfusion imaging after an initial positive 
coronary computed tomography  angiography (CCTA) using invasive coronary angiography (ICA) 
with conditional fractional flow reserve (FFR) as reference.  Secondly we aimed to identify factors 
associated with revascularisation and to evaluate treatment outcome after ICA. 
 
Methods 
We analysed 292 consecutive patients with suspected significant coronary artery disease (CAD) at 
CCTA, who underwent perfusion imaging with either cardiac magnetic resonance (CMR) or 
myocardial perfusion scintigraphy (MPS) followed by ICA with conditional FFR. Stratified 
analysis and uni- and multiple logistic regression analyses were performed to identify predictors of 
diagnostic agreement between perfusion scans and ICA and predictors of revascularisation.  
 
Results 
Myocardial ischemia evaluated with perfusion scans was present in 65/292 (22%) while 117/292 
(40%) had obstructive CAD evaluated by ICA. Revascularisation rate was 90/292 (31%). The 
overall sensitivity for perfusion scans was 39 % (30-48), specificity 89 % (83-93), PPV 69 % (57-
80) and NPV 68 % (62-74). Stratified analysis showed higher sensitivities in patients with multi-
vessel disease at CCTA 49 % (37-60) and typical chest pain 50 % (37-60). Predictors of 
revascularisation were multi-vessel disease by CCTA (OR 3.51 [1.91-6.48]) and a positive 
perfusion scan (OR 4.69 [2.49-8.83]).  
 
Conclusion 
The  sensitivity for perfusion scans after CCTA was highest in patients with typical angina and 
multiple lesions at CCTA and predicted diagnostic agreement between perfusion scans and ICA. 
Abnormal perfusion and multi vessel disease at CCTA predicted revascularisation.   
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Introduction  
Despite guideline recommendations of non-invasive imaging testing for diagnosing stable coronary 
artery disease (CAD) in patients with low/intermediate pre-test probability of CAD [1,2], invasive 
coronary angiography (ICA) continues to be used early on in the diagnostic pathway in patients 
with suspected CAD. Evidence from large populations presenting with chest pain has confirmed 
that the majority will not have obstructive CAD [3,4]. Moreover, a large US study reported that 
approximately 60 % of elective ICAs found no obstructive CAD [5]. Avoiding unnecessary ICA 
would reduce patient risk and provide significant financial savings. 
 
Non-invasive testing depicts anatomy, detects coronary atherosclerosis or identifies myocardial 
ischemia. Coronary computed tomography angiography (CCTA) assesses coronary anatomy [6] and 
is particularly useful for exclusion of CAD in low/intermediate-risk patients due to the high 
negative predictive value (NPV). Perfusion imaging e.g. cardiac magnetic resonance (CMR) or 
myocardial perfusion scintigraphy (MPS) assesses myocardial ischemia and the modalities provides 
strong prognostic information on mortality and morbidity [7,8].  
  
Several head-to-head studies have evaluated a combined diagnostic set-up with CCTA and 
perfusion imaging in high risk patients [9,10]. 
In the Danish study of Non-Invasive testing in Coronary Artery Disease (Dan-NICAD) 1 trial 
[11,12], the diagnostic accuracy of perfusion imaging with either CMR or MPS was tested in 
patients with significant CAD on CCTA, using ICA + conditional FFR measurements as the 
reference standard. In contrast to studies conducted in patients with high pre-test risk evaluated 
clinically, we found low sensitivity for both perfusion techniques [12]. 
 
The primary aim of this Dan-NICAD 1 sub-study was to evaluate if clinical parameters and CAD 
severity added independent predictive value to the diagnostic performance of perfusion imaging in 
patients with a low/intermediate risk of CAD and a CCTA suggestive of CAD. Secondarily, we 
evaluated the treatment outcome after ICA to further analyse the clinical consequence of potentially 
using perfusion imaging as a second line test instead of ICA. 
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Methods 
 
Patients and study design 
This was a sub-study comprising all randomized patients from the Dan-NICAD 1 trial with a CCTA 
result suggesting obstructive CAD[12]. A detailed description of the Dan-NICAD 1 trial has been 
published [11]. In short, the trial was a two-centre, randomised, open label, head-to-head clinical 
trial including consecutive patients referred for CCTA with low/intermediate risk of CAD 
(n=1675). Patients suspected of obstructive CAD at CCTA (n=392) were randomized 1:1 to CMR 
or MPS and scheduled for subsequent ICA with conditional FFR. The core labs analysing the CMR 
and MPS scans were blinded to clinical information and the results of the ICA. Physicians 
performing ICA-FFR decided patient treatment blinded to the results of the perfusion scans.  
The study followed the Declaration of Helsinki. The Danish Data Protection Agency and the 
Central Denmark Regional Committee on Health Research Ethics approved the study. All patients 
provided informed written consent.  
The study was registered at ClinicalTrials.gov (identifier: NCT02264717).  
 
Procedures 
Coronary computed tomography angiography 
CCTA scans were performed using a 320 slice volume CT scanner (Aquillion One, Toshiba 
Medical Systems, Japan) with prospective electrocardiographic (ECG) gating. The images were 
analysed on a dedicated workstation (Vitrea Advanced Workstation, Vital Images, USA) by an 
experienced cardiologist. Luminal diameter stenosis was evaluated in each segment using the 18-
segment Society of Cardiovascular Computed Tomography (SCCT) model [13]. Coronary lesions 
were quantified for stenosis by visual assessment; and severity was classified as no stenosis: 0% 
diameter reduction; mild stenosis: 1% to 29% diameter reduction; moderate stenosis: 30% to 49% 
diameter reduction; and severe stenosis: 50% to 100% diameter reduction. Severe stenosis and non-
evaluable segments with a diameter exceeding 2 mm were defined as obstructive CAD.  
   
Myocardial perfusion scintigraphy 
MPS was obtained using a dedicated gamma camera (Cardio MD, Phillips Healthcare, Best, 
Holland). Patients conducted a standard symptom-limited bicycle exercise test preceded by 48 
hours beta-blocker withdrawal. If patients were unable to reach target heart rate (≥85% of 220-age), 
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adenosine stress was performed. If stress images revealed any abnormalities, a resting study was 
obtained. 
Images were analysed using Cedar Sinai AutoQuant software by an independent core lab 
(Department of Nuclear Medicine, Aarhus University Hospital, Aarhus, Denmark) using a 17-
segment model. For each segment, the perfusion defect was scored in a 5-point scoring system (0: 
normal and up to 4: absence of tracer uptake) and summed into a summed stress score (SSS), 
summed rest score (SRS) and summed difference score (SDS). Images were also evaluated 
qualitatively with a binary outcome (normal/abnormal). An abnormal MPS scan was defined as 1) 
an SDS ≥4 involving ≥ 2 contiguous segments (reversible defect), 2) an SRS ≥4 involving ≥ 2 
contiguous segments (irreversible defect) 3) a combination of 1) and 2) (mixed defect).  
Cardiac magnetic resonance imaging  
The CMR scans were conducted using a 1.5 Tesla system (Siemens MAGNETOM Avanto, 
Siemens Healthcare GmbH, Erlangen, Germany). Stress perfusion imaging was conducted after 
intravenous injection of either 0.4 mg (5 ml) of Regadenosone® (Lexiscan, Astellas Pharma, USA) 
or intravenous adenosine-induced hyperaemia 140 μg/kg/min over 4 minutes. A stepwise increase 
in adenosine dose was administered in case of inadequate response. For adenosine stress an increase 
of > 10 bpm or a blood pressure reduction >10 mm Hg from baseline was considered sufficient 
[14]. For Regadenosone® an increase in heart rate of > 10 bpm was considered a sufficient clinical 
response. Splenic switch-off was registered in all patients stressed with adenosine. As contrast 
agent, either Gadovist® (Bayer Schering Pharma AG, Germany) or Dotarem® (GD-DOTA, 
Guerbet LCC, USA), was used. 
CMR analysis was performed in an independent core lab (William Harvey Research 
Institute, Queen Mary University of London, London, United Kingdom) blinded from additional 
patient information and results. Diagnostic confidence was evaluated using a scale from 1-3, 
indicating high, medium or low image quality. Images were evaluated qualitatively with a binary 
outcome (normal/abnormal) based on the perfusion analysis. Significant perfusion defects were 
defined as subendocardial or transmural signal changes by stress imaging or irreversible defects in 
≥2 contiguous segments by late gadolinium enhancement (LGE) imaging.  
 
Invasive coronary angiography with fractional flow reserve 
ICA was performed approximately 4 weeks after CCTA using a routine procedure. FFR 
measurements (St. Jude Medical, MN, USA and Volcano, San Diego, USA) were performed if 
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technically possible in all coronary segments with a diameter > 2 mm where ICA showed a stenosis 
with a diameter ≥ 30 and <90% by visual assessment. All pressure waveforms were analysed by a 
core lab (Interventional Coronary Imaging Core Laboratory, Aarhus University Hospital, 
Denmark). 
Two-dimensional (2D) quantitative coronary analysis (QCA) was performed in an independent core 
lab (ClinFact, Leiden, The Netherlands) using QAngioXA 7.3 QCA software. Haemodynamically 
obstructive CAD was defined as FFR ≤0.80, or as a visual high-grade stenosis (>90% diameter 
stenosis) in a vessel with a reference diameter above ≥2.0 mm. If FFR was not technically possible, 
a QCA-measured stenosis exceeding ≥50% diameter stenosis defined a significant lesion.  
 
 
Statistical analysis 
 
Continuous variables were expressed using mean (±SD) and categorical variables as frequency (n, 
%). Frequencies were compared by Fischer's exact test or Chi-square test as appropriate. The 
perfusion scans were analysed as one group due to the similar diagnostic performance of the CMR 
and MPS [12]. Only patients with complete data were included in the analyses. Data were binary 
grouped by sex, age (above/below 60 years), clinical presentation (+/- typical angina), CACS 
(above/below of 400) and single vs. multi-vessel disease by CCTA and the associated sensitivities, 
specificities and predictive values were calculated. These strata and the perfusion data were added 
to logistic regression models as independent variables to identify possible predictors of 
revascularisation after ICA (dependent variable). Model overfitting was balanced by limiting 1 
variable in the multi-variable model for every 10 outcome. All results were presented with 95% CI 
and two-sided p-value <0.05 were considered statistically significant.  
Statistical analysis was performed using STATA-15 (StataCorp, College Station, TX, USA). 
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Results 
 
Patient characteristics 
A total of 292 patients with suspected obstructive CAD on CCTA completed perfusion imaging 
with either CMR or MPS followed by ICA. Among these, 148 patients completed CMR and ICA 
and 144 completed MPS and ICA. Study flowchart and baseline characteristics are presented in 
Figure 1 and Table 1.   
Imaging characteristics including CACS, CCTA, perfusion imaging and ICA are also presented in 
Table 1. Significant perfusion defects were identified in 65/292 (22 %) patients. In the 27 patients 
with a positive MPS, SSS, SRS and SDS were 11.2 ±6.2, 4.2 ±3.4 and 7.6 ±5.3, respectively 
(mean±2SD). In the 38 patients with a positive CMR, the number of segments with a perfusion 
defect was 5.1±2.3 (mean±2SD). The reference test (ICA with conditional FFR) classified 117/292 
(40%) patients with obstructive CAD, 75 due to a FFR ≤0.80, the rest a high-grade stenosis. FFR  
was measured in 167 patients and mean FFR was 0.83 ±0.09. Accuracy measures for the whole 
population are presented in Figure 2. Forty-five patients had coinciding abnormal perfusion 
imaging and obstructive CAD at ICA and 155 coinciding normal perfusion and non-obstructive 
CAD, Table 3 and Figure 2, yielding an accuracy of 68%. Case examples of false negative and true 
positive CMR and MPS images are presented in Figure 3 and Figure 4. 
 
Stratified analysis on patient related factors, coronary artery calcium score, and disease severity 
on the performance of perfusion imaging 
Stratification was performed according to sex, age above or below 60 years, clinical presentation, 
CACS above or below 400 and single/multi vessel disease at CCTA as shown in Table 2. Except  
sensitivity and positive predictive value (PPV) for multi- vs. single vessel disease, the 95% CI 
intervals overlapped (Marked with fat typing in table 2). 
The proportion and absolute numbers of correctly classified patients with no CAD, one, two 
or three vessel disease is presented in Table 3. The proportion of correctly classified patients 
improved significantly for one vs. two vessel CAD (p=0.025) and for one vs. three vessel CAD 
(p=0.01).  
 
Logistic regression models estimating predictors for diagnostic agreement between perfusion 
imaging and invasive coronary angiography and regression models predicting revascularisation 
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The same variables used for stratification were also used in the regression models and the result of 
the perfusion imaging was included as a variable.  
 OR for diagnostic agreement between perfusion imaging and ICA, was significantly higher at 
multi-variable regression analysis for typical angina, (p=0.03) and multi-vessel disease by CCTA, 
(p<0.01). All results from uni- and multi-variable regression analysis are presented in Table 4. In 
the multi-variable regression analysis, significant predictors of revascularisation after ICA were 
multi-vessel disease by CCTA, (p<0.01) and positive perfusion imaging, (p<0.01). All results are 
presented in Table 5.  
 
Treatment consequence after invasive coronary angiography 
The clinical treatment consequences are presented in Figure 5. Of the 292 patients, 91 (31%) were 
revascularized with percutaneous coronary intervention (PCI) (47, 52%), J-incision off pump 
coronary artery bypass (JOPCAB) (7, 8%), coronary total occlusion (CTO) (4, 4%) or coronary 
artery bypass grafting (CABG) (33, 36%). Another 27 patients (9%) with abnormal ICA were 
treated medically based on a clinical decision, 5 of these had an abnormal perfusion scan.  
Among the 91 revascularized patients, 40 (44%) had a positive perfusion test and 51 (56%) had a 
normal perfusion test.  Revascularization was performed in 62 % (40/65) patients with abnormal 
perfusion and in 22 % (50/227) with a normal perfusion. Of the patients with normal perfusion, 32 
underwent PCI, 4 JOPCAB (25 with one-vessel disease, 10 with two-vessel disease and 1 with 
three-vessel disease) and 14 CABG (7 with one-vessel disease, 5 with two-vessel disease and 2 with 
three-vessel disease). The revascularisation strategy was different as patients with abnormal 
perfusion underwent more extensive procedures (CTO and CABG) compared to patients with 
normal perfusion (PCI and JOPCAB), p=0.004.  
One patient undergoing PCI had a normal ICA according to our diagnostic criteria, but during the 
ICA a clinical decision of revascularisation was made 
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Discussion 
In the Dan-NICAD 1 trial, we found a sensitivity of 39% and a specificity of 89% for perfusion 
imaging (CMR and MPS) using ICA with conditional FFR as reference standard, in symptomatic 
patients with a CCTA suspected of obstructive CAD. Subgroup analyses in the present paper 
revealed that the sensitivity of perfusion imaging was slightly higher (around 50%) in patients with 
typical angina and multi-vessel disease at CCTA. In accordance with this, we showed that typical 
angina and multi-vessel disease had an independent predictive value regarding abnormal ICA. 
Additionally, we noticed that multi-vessel disease at CCTA and a positive perfusion scan, but not 
typical angina, were independent predictors of revascularisation. Suggestively, only half of the 
revascularized patients, including patients undergoing CABG, had abnormal perfusion.   
 
Many former studies testing perfusion imaging with CMR or MPS against ICA with either QCA or 
FFR showed high sensitivities (70-90 %) and specificities (75-94 %) [7,9,15-17]. The inclusion 
criteria and pre-test likelihood of CAD in these studies were diverse. In the present study, patients 
were included according to the CCTA findings, i.e. beforehand selected as suitable for this modality 
implying low/intermediate risk with a frequent prevalence of atypical symptoms and one-vessel 
disease (54%)  [12]. A recent Danish study including 143 patients from CCTA calculated similar 
diagnostic values of MPS including a sensitivity of 41%, indicating that patients selected by CCTA 
have a lower ischemic burden than patients traditionally referred for MPS [18]. This is well 
understood considering that many high-risk patients are excluded from CCTA due to e.g. high BMI, 
high age, suspicion of high CACS (e.g. diabetics of whom we only have 22 (8%) in the trial), 
irregular hear rhythm or kidney disease.  Among the positive perfusion scans in the present study, 
50/65 (77%) covered 2-3 vessel territories, indicating that a larger ischemic burden is needed to 
cause substantial myocardial ischemia detected by perfusion imaging. 
Obstructive multi-vessel disease by CCTA was an independent predictor of both diagnostic 
agreement between perfusion imaging and ICA and revascularisation. This is in concordance with 
the CONFIRM study showing multi-vessel disease to be the strongest predictor of ICA utilization 
after CCTA [19]. The results from the regression analysis indicate that disease severity and extent is 
part of the explanation for the low overall sensitivity in the Dan-NICAD trial, as most patients have 
one-vessel CAD and atypical symptoms.  
 
12 
 
The Dan-NICAD 1 trial raises the question whether to manage patients according to the results of 
perfusion scan or ICA. Patient management can be driven by prognosis or symptoms. A strong 
argument for prognosis guided management is the widely accepted fact that a normal perfusion 
carries a favourable patient outcome [20-22]. A recent study evaluating a diagnostic strategy using 
positron emission tomography (PET) perfusion in patients with suspected CAD at CCTA [22] 
showed event rates 5 times higher for patients with an abnormal PET compared to a normal PET . 
In addition, event rates were similar for patients with a normal PET and an abnormal CCTA 
compared to patients with a normal CCTA. This study population resembles the Dan-NICAD 
patients and we expect a similar favourable outcome for patients with normal perfusion in our trial. 
Whether revascularisation with PCI improves patient prognosis in terms of mortality is debated.   
The COURAGE trial [23] evaluated the effect of revascularisation with PCI and optimal medical 
therapy (OMT) in patients with stable CAD or OMT alone and found no difference in terms of 
prognosis. Oppositely FAME 2 found reduced event rates in patients with stable CAD treated with 
FFR guided PCI and OMT compared to OMT alone [24]. The COURAGE trial nuclear sub-study 
showed that treatment with PCI + OMT in patients with myocardial ischemia at MPS reduced risk 
of death and cardiac events, especially in patients with moderate to severe ischemia [25]. 
Interestingly, if our patients had been treated according to the result of the perfusion scan, only 20% 
((292-65)/292) would have been referred for ICA, presumably without impact of prognosis! 
Furthermore around half of the revascularisation procedures (50/90) would have been saved. These 
high percentages seem provocative and challenge current patient management strategies.  
Performing symptom driven treatment, the anti-anginal effect of revascularisation is the primary 
goal. Little substantial knowledge exists regarding this management strategy, and the 
pathophysiology of angina is complex. It can be speculated that revascularisation of larger ischemic 
areas detected by MPS / CMR provides more pronounced symptom relief compared to treatment of 
smaller areas of ischemia although the supplying vessel to this area has a FFR below 0.8. However, 
we do not know whether the clinical benefit of revascularisation differed between patients with or 
without perfusion defects in our study population.  
In our study 51 patients without a perfusion defect were revascularized; some will argued that these 
patients were missed calls by perfusion imaging and others will state that these patients were over 
treated. As FFR is measured in epicardial arteries > 2 mm and CMR/MPS detects ischemia at tissue 
level, it is possible that the discrepancy between the two examinations merely reflects the different 
nature of the modalities rather than the inferiority of the one over the over. 
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Many years ago Diamond and Forrester published a highly cited paper on how to use probability as 
an aid in the clinical diagnosis of CAD[26]. Their data revealed that CAD was far more common 
among patients with typical angina compared to atypical angina and non-cardiac chest pain. 
Although questioning a patient about symptoms remains a corner stone in modern cardiology, we 
nowadays do not base diagnosis on clinical information alone. In this perspective, we find it 
interesting that out of other known high-risk markers of CAD (age, gender, CACS), typical angina 
turns out to be the one correlating with ischemia, emphasising that clinical history should not be 
forgotten in a world of advanced technology. 
Given the discrepancy between the invasive and non-invasive techniques it seems that the 
population of patients with initially low to intermediate risk of CAD and a CCTA suggestive of 
obstructive CAD constitute a particular challenge for perfusion scans.  
This study adds an important contribution to the on-going discussion on which diagnostic strategy 
to use in patients suspected of CAD and specifically address the problems evolving from comparing 
results of diagnostic methods evaluating CAD on a vessel level and myocardial level. 
However, results from studies quantifying flow from perfusion imaging and estimating absolute 
flow during FFR will likely help to further clarify the discrepancy observed between the invasive 
and non-invasive techniques. 
 
 
 
Limitations  
 
Not all patients in this cohort obtained a complete dataset. Patients with incomplete data, 
approximately 25 % of the randomized patients, did not complete the entire study protocol for 
various reasons specified in Figure 1. However this is not unexpected and similar findings were 
seen in e.g. the EVINCI study [27]. Patients did not drop out or were selected but the missing data 
mainly occurred due to logistic reasons as examinations were spread on multiple days and locations 
and this would not have influenced the prevalence of disease. Also FFR was not measured in all 
vessels but only in lesions with a diameter stenosis between (30-90 %) evaluated by the clinician 
performing the procedure. Performing FFR measures in all lesions might have changed the number 
of patients classified with CAD. Patients with a recent myocardial infarct, previous 
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revascularisation with PCI or CABG were not included in this study and the results can therefore 
not be generalized to patients with known CAD.  
 
Conclusion  
In patients suspected of CAD and a CCTA with obstructive CAD, the sensitivity for perfusion scans 
were in general low compared to a reference standard of ICA with conditional FFR, but improved 
significantly in patients with typical chest pain symptoms and multi-vessel disease by CCTA. 
Multi-vessel disease at CCTA and abnormal perfusion predicted revascularisation.   
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Table 1: Baseline characteristics and patient characteristics according to CACS, CCTA, perfusion 
imaging, and ICA 
    
    Patients per protocol 
 
   Total CMR MPS 
   (N=292) (N=148)  (N=144)  
 
Gender, Women, n  118 (40%) 60 (41%) 58 (40%)   
Age, Y   61.3±8.1 61.9±7.9 60.8±8.1  
BMI, mean   26.9±3.9 26.8±3.9 27.1±4.0  
   
Risk factors    
  Current smoking  52 (18%) 23 (16%) 29 (20%)   
  Antihypertensive treatment  135 (46%) 75 (51%)      60 (42%)   
  Lipid-lowering treatment  91 (32%) 48 (33%) 43 (30%)   
  Diabetes   22 (8%) 14 (10%) 8 (6%)   
  Family history of early CAD#  123 (42%) 60 (41%) 63 (44%)     
     
Symptoms    
  Typical angina  94 (32%) 47 (32%) 47 (33%)   
  Atypical angina  94 (32%) 52 (35%) 42 (29%)   
  Non-angina chest pain  43 (15%) 20 (14%) 23 (16%)               
  Dyspnea or arrhythmia  61 (21%) 29 (20%) 32 (22%) 
 
Pretest probability*  
  Low (<0.15)   14 (5%) 8 (5%) 6 (4%) 
  Moderate (>=0.15 & <0.85)  261 (89%) 132 (89%) 129 (90%) 
  High (<=0.85)   17 (6%) 8 (5%) 9 (6%) 
      
CACS     
 - CACS<400   183 (63%) 88 (60%) 95 (66%) 
 - CACS≥400    109 (37%) 60 (40%) 49 (34%) 
 
CCTA*     
- One-vessel CAD  157 (54%) 77 (52%) 80 (56%)   
- Two-vessel CAD  75 (26%) 42 (28%) 33 (23%) 
- Three-vessel or LM CAD  59 (20%) 29 (20%) 30 (21%) 
 
Perfusion imaging    
- Abnormal perfusion  65 (22%) 37 (25%) 27 (19%)  
- Poor Image quality  1 (0.3%) 1 (0.7%) 0 (0%) 
- One-vessel territory  14 (5%) 8 (5%) 6 (4%)   
- Two-vessel territory  37 (13%) 25 (17%) 12 (8%) 
- Three-vessel territory  13 (4%) 4 (3%) 9 (7%) 
    
ICA     
CAD   117 (40%) 59 (40%) 58 (41%) 
- One-vessel CAD  69 (24%) 33 (22%) 36 (25%) 
- Two-vessel CAD  32 (11%) 19 (13%) 13 (9%) 
- Three-vessel or LM CAD  16 (5%) 7 (5%) 9 (6%) 
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Values are n (%) or mean±SD. CMR: Cardiac magnetic resonance imaging, MPS: Myocardial perfusion scintigraphy 
BMI: body mass index, CCTA: Coronary computed tomography angiography. ICA: invasive coronary angiography. 
CACS: coronary artery calcium score 
# Family history of coronary artery disease among 1'st degree relatives before the age of 60. 
* Pre-test probability assessed using the updated Diamond-Forrester score. 
*One patient was randomized without a CCTA due to a high calciumscore.  
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Table 2: Stratified analysis on diagnostic accuracy for perfusion imaging vs. ICA  
 
 Prevalence of CAD Sensitivity Specificity PPV NPV 
Female 36/118 (31%) 33% (19-51) 88% (79-94) 55% (32-76) 75% (65-83) 
Male 81/174 (47%) 41% (30-52) 89% (81-95) 77% (61-88) 63% (55-72) 
AGE<60 45/110 (41%) 31% (18-47) 85% (74-92) 58% (37-78) 64% (53-74) 
AGE≥60 72/182 (40%) 43% (31-55) 91% (84-96) 76% (60-88) 71% (63-78) 
Typical 
angina 42/94 (45%) 50% (34-66) 85% (72-93) 72% (53-87) 68% (55-79) 
Other* 75/198 (38%) 32% (22-44) 90% (84-95) 67% (49-81) 69% (61-76) 
CACS <400 63/183 (34%) 32% (21-45) 87% (79-92) 56% (38-72) 71% (63-78) 
CACS ≥400 54/109 (50%) 46% (33-60) 93% (82-98) 86% (68-96) 64% (52-74) 
Single-vessel 
(CCTA) 41/157 (26%) 20% (9-35) 86% (79-92) 33% (16-55) 75% (67-82) 
Multi-vessel 
(CCTA) 76/134 (57%)  49% (37-60) 93% (83-98) 90% (77-97) 58% (47-68) 
 
Stratified analyses on sex, age±60, typical angina symptoms or *other covering atypical, non-specific, dyspnoea or 
arrhythmia, CACS±400 and single vs. multi-vessel disease classified by CCTA.  
Values are proportions and 95 % CI are shown in the parentheses. All analyses are per-patient. 
 
CAD: coronary artery disease, PPV: positive predictive value, NPV: negative predictive value, CACS: coronary artery 
calcium score, CCTA: coronary computed tomography tomography. 
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Table 3: Patients with single or multi-vessel CAD by ICA  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Numbers in parentheses are proportions of correctly classified patients. The total proportion of correctly classified 
patients are (155+19+16+10)/292 68 %. 
CAD: coronary artery disease, ICA: invasive coronary angiography LM: Left main 
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by
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Perfusion imaging 
 Normal Abnormal Total 
No CAD 155 (89%) 20   175  
One-vessel CAD 50   19  (28%) 69  
Two-vessel CAD 16   16 (50%) 32 
Three-vessel CAD or 
LM CAD 6   10 (63%) 16 
Total 227   65   292  
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Table 4: Simple and multiple logistic regressions to identify predictors of diagnostic agreement 
between perfusion imaging and ICA 
 
Variable (Reference group) Simple logistic regression model, OR  
Multiple logistic regression 
model, OR 
Female 
 
Male 
 
 
1.40 (0.60-3.13; p=0.45) 
 
 
1.61 (0.65-3.95; p=0.30) 
Age<60 
 
Age≥60 
 
 
1.67 (0.76-3.67; p=0.19) 
 
 
1.34 (0.55-3.25; p=0.52) 
Chest pain other* 
 
Typical 
 
 
2.13 (0.98-4.61; p=0.06) 
 
 
2.57 (1.11-5.98; p=0.03) 
CACS<400 
 
CACS≥400 
 
 
1.85 (0.87-3.94; p=0.12) 
 
 
0.95 (0.38-2.36; p=0.91) 
Single-vessel by CCTA 
 
Multi-vessel by CCTA 
 
 
 3.91 (1.60-9.57; p<0.001) 
 
 
 4.53 (1.61-12.71; p<0.001) 
 
Simple and multiple logistic regression models to identify predictors of diagnostic agreement between perfusion 
imaging and ICA. Values are (95 % CI; p-value) 
*Other covering atypical, non-specific, dyspnoea or arrhythmia 
ICA: Invasive coronary angiography, OR: odds ratio, CACS: coronary artery calcium score, CCTA: coronary computed 
tomography angiography. 
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Table 5: Simple and Multiple logistic regression predictors of revascularisation  
 
Variable (Reference group) Simple logistic regression model OR 
Multiple logistic regression 
model OR  
Female 
 
Male 
 
 
1.70 (1.01- 2.86; p=0.05) 
 
 
1.47 (0.82-2.64; p=0.19) 
Age<60 
 
Age≥60 
 
 
0.89  (0.54- 1.48; p=0.65) 
 
 
0.67 (0.37-1.21; p=0.19) 
Chest pain other* 
 
Typical 
 
 
1.31 (0.77 -2.20; p=0.32)  
 
 
1.06 (0.58-1.94; p=0.84) 
CACS<400 
 
CACS≥400 
 
 
2.24 (1.35-3.72; p=0.002) 
 
 
1.47 (0.80-2.72; p=0.21) 
CCTA CAD extent (Single-
vessel) 
 
Multi-vessel 
 
 
4.40 (2.58-7.52; p<0.001) 
 
 
3.51 (1.91-6.48; p<0.001) 
No perfusion defect 
 
Perfusion defect 
 
 
5.52 (3.06-9.95; p< 0.001) 
 
 
4.69 (2.49- 8.83; p<0.001) 
 
Simple and multiple logistic regression models to identify predictors of revascularisation. Values are (95 % CI; p-value) 
*Other covering atypical, non-specific, dyspnoea or arrhythmia 
ICA: Invasive coronary angiography, OR: odds ratio, CACS: coronary artery calcium score, CCTA: coronary computed 
tomography angiography.  
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Figure 1: Patient flowchart.   
CCTA: coronary computed tomography angiography, CMR: cardiac magnetic resonance, MPS: myocardial perfusion 
scintigraphy, ICA: invasive coronary angiography, CACS: coronary artery calcium score. 
 
Figure 2: Results of perfusion imaging compared with invasive angiography with conditional FFR  
2.a Sensitivity, specificity, PPV and NPV measured at the patient level for the perfusion imaging. Results are presented 
with 95% CI. 
2.b: Results in absolute numbers at patient level.  
PPV: positive predictive value, NPV: negative predictive value, ICA: invasive coronary angiography.  
 
Figure 3: Two case examples of CCTA, MPS and ICA findings 
Upper example; a false negative MPS: CCTA showed diffuse mixed calcified and soft plaques throughout LAD. Both 
rest and stress MPS were normal without perfusion defects. ICA showed an elongated severe stenosis in LAD visually 
assessed as >90 % stenosis. Patient was treated with a graft, LIMA to LAD. 
Lower example; a true positive MPS: CCTA showed a severe proximal stenosis in LAD, the plaque was mixed soft 
and calcified. Stress and rest MPS showed both fixed and reversible perfusion defects in the anterior wall. ICA showed 
an occluded LAD with only retrograde contrast filling. The patient was treated with PCI in the proximal LAD. 
CCTA: coronary computed tomography angiography. MPS: myocardial perfusion scintigraphy. ICA: invasive coronary 
angiography. LAD: left anterior descending artery. LIMA: left internal mammary artery. PCI: percutaneous coronary 
intervention. 
 
Figure 4: Two case examples of CCTA, CMR and ICA findings 
Upper example; a false negative CMR: CCTA showed diffuse mixed calcified and soft plaques throughout LAD. 
Stress CMR was normal without hypo perfused areas.  ICA showed an elongated stenosis in LAD, FFR was 0.72. The 
patient was treated with a graft, LIMA to LAD 
Lower example; a true positive CMR; CCTA showed severe calcified plaques throughout LAD. Stress CMR showed 
a large transmural perfusion defect in the antero-septal wall. ICA showed an occluded LAD with only retrograde 
contrast filling. The patient was treated with CABG, grafts for LAD and RCA. 
CCTA: coronary computed tomography angiography. CMR: cardiac magnetic resonance, ICA: invasive coronary 
angiography. LAD: Left anterior descending artery. FFR: fractional flow reserve. LIMA: left internal mammary artery. 
CABG: coronary artery bypass grafting. RCA: right coronary artery. 
 
Figure 5: Treatment consequence of ICA stratified by the results of perfusion imaging 
ICA: invasive coronary angiography, JOPCAB: J-incision off pump coronary artery bypass, PCI: percutaneous 
coronary intervention, CTO: coronary total occlusion, CABG: coronary artery bypass grafting.  
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